Real-time enrollment status for this glomerulonephritis clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 6:32 PM UTC
| NCT Number | NCT05755386 |
| Recruiting Status | Recruiting |
| Condition | Glomerulonephritis |
| Phase | PHASE3 |
| Target Enrollment | 106 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | July 13, 2026 (Jul 13, 2026) |
As of September 1, 2026: Clinical trial NCT05755386 is currently recruiting participants. This phase3 study for glomerulonephritis is actively seeking new participants at 22 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05755386 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05755386 was last updated Jul 13, 2026 (July 13, 2026). HelloStudys verifies this status automatically.